| Fitness type Others | Locality DLF City Phase II |
Metastatic Renal Cell Carcinoma (mRCC) is an aggressive devastating disease. For patients who present with advance stage mRCC their median survival is hardly 15 months and majority of them ultimately die.
Website:- http://www.apacbiotech.com/renal-cell-carcinoma-cancer.html